BrainStorm Cell Therapeutics
BCLI
#10953
Rank
NZ$17.02 M
Marketcap
NZ$1.54
Share price
-8.96%
Change (1 day)
33.60%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -NZ$18.33 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$18.41 Million, an increase over its 2024 earnings that were of -NZ$20.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$18.33 Million-0.46%
2025 -NZ$18.41 Million-11.32%
2024 -NZ$20.76 Million-32.39%
2023 -NZ$30.71 Million-29.18%
2022 -NZ$43.37 Million-0.74%
2021 -NZ$43.69 Million-23.12%
2020 -NZ$56.82 Million36.8%
2019 -NZ$41.54 Million66.71%
2018 -NZ$24.92 Million181.66%
2017 -NZ$8.85 Million-0.6%
2016 -NZ$8.9 Million-41.31%
2015 -NZ$15.17 Million-8.22%
2014 -NZ$16.52 Million89.74%
2013 -NZ$8.71 Million42.27%
2012 -NZ$6.12 Million-12.45%
2011 -NZ$6.99 Million63.04%
2010 -NZ$4.29 Million35.52%
2009 -NZ$3.17 Million-48.99%
2008 -NZ$6.21 Million-44.39%
2007 -NZ$11.16 Million
2005 -NZ$5.78 Million-91.44%
2004 -NZ$67.48 Million94007.62%
2003 -NZ$0.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
NZ$1.80 B-9,712.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-NZ$3.5 Billion 18,480.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-NZ$1.42 Billion 7,413.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.6 Billion 8,396.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.26 B-1,535.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-NZ$0.46 Billion 2,328.14%๐Ÿ‡บ๐Ÿ‡ธ USA